Medlive Technology Dividends and Buybacks
Dividend criteria checks 1/6
Medlive Technology is a dividend paying company with a current yield of 2.27% that is well covered by earnings. Next payment date is on 6th June, 2025 with an ex-dividend date of 12th May, 2025.
Key information
2.3%
Dividend yield
-0.03%
Buyback Yield
| Total Shareholder Yield | 2.2% |
| Future Dividend Yield | 2.1% |
| Dividend Growth | n/a |
| Next dividend pay date | 06 Jun 25 |
| Ex dividend date | 12 May 25 |
| Dividend per share | n/a |
| Payout ratio | 59% |
Recent dividend and buyback updates
Recent updates
What Medlive Technology Co., Ltd.'s (HKG:2192) 25% Share Price Gain Is Not Telling You
May 07
Here's Why Shareholders May Want To Be Cautious With Increasing Medlive Technology Co., Ltd.'s (HKG:2192) CEO Pay Packet
May 01Medlive Technology (HKG:2192) Shareholders Should Be Cautious Despite Solid Earnings
Apr 21Medlive Technology (HKG:2192) Could Be Struggling To Allocate Capital
Apr 09Optimistic Investors Push Medlive Technology Co., Ltd. (HKG:2192) Shares Up 26% But Growth Is Lacking
Feb 12Should You Be Adding Medlive Technology (HKG:2192) To Your Watchlist Today?
Jan 06Be Wary Of Medlive Technology (HKG:2192) And Its Returns On Capital
Dec 04Investors Shouldn't Be Too Comfortable With Medlive Technology's (HKG:2192) Earnings
Oct 02Pinning Down Medlive Technology Co., Ltd.'s (HKG:2192) P/E Is Difficult Right Now
Sep 27Medlive Technology (HKG:2192) Could Be Struggling To Allocate Capital
Jul 04Medlive Technology Co., Ltd.'s (HKG:2192) Business Is Yet to Catch Up With Its Share Price
Apr 08Medlive Technology (HKG:2192) Is Reinvesting At Lower Rates Of Return
Feb 20Are Medlive Technology Co., Ltd. (HKG:2192) Investors Paying Above The Intrinsic Value?
Jan 10Medlive Technology Co., Ltd.'s (HKG:2192) Intrinsic Value Is Potentially 20% Below Its Share Price
Sep 27Medlive Technology (HKG:2192) Is Reinvesting At Lower Rates Of Return
Jul 10Medlive Technology Co., Ltd. (HKG:2192) Shares Slammed 28% But Getting In Cheap Might Be Difficult Regardless
May 11Robust Earnings May Not Tell The Whole Story For Medlive Technology (HKG:2192)
May 02Results: Medlive Technology Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates
Mar 26Here's What's Concerning About Medlive Technology's (HKG:2192) Returns On Capital
Feb 06There Are Reasons To Feel Uneasy About Medlive Technology's (HKG:2192) Returns On Capital
Oct 31Medlive Technology (HKG:2192) Could Be Struggling To Allocate Capital
Jul 14These Analysts Just Made A Massive Downgrade To Their Medlive Technology Co., Ltd. (HKG:2192) EPS Forecasts
Apr 03Is Medlive Technology Co., Ltd. (HKG:2192) Worth HK$9.5 Based On Its Intrinsic Value?
Feb 22Upcoming Dividend Payment
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, 2192 has been paying a dividend for less than 10 years.
Growing Dividend: 2192's dividend payments have increased, but the company has only paid a dividend for 3 years.
Dividend Yield vs Market
| Medlive Technology Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (2192) | 2.3% |
| Market Bottom 25% (HK) | 3.0% |
| Market Top 25% (HK) | 7.8% |
| Industry Average (Healthcare Services) | 1.1% |
| Analyst forecast (2192) (up to 3 years) | 2.1% |
Notable Dividend: 2192's dividend (2.27%) isn’t notable compared to the bottom 25% of dividend payers in the Hong Kong market (3.02%).
High Dividend: 2192's dividend (2.27%) is low compared to the top 25% of dividend payers in the Hong Kong market (7.82%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonable payout ratio (59.5%), 2192's dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its high cash payout ratio (215.5%), 2192's dividend payments are not well covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/07 05:23 |
| End of Day Share Price | 2025/05/07 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Medlive Technology Co., Ltd. is covered by 8 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shuo Song | Citic Securities Co., Ltd. |
| Luoxin Jiang | Citic Securities Co., Ltd. |
| Zhu Chen | Citic Securities Co., Ltd. |